Reflections on Lumenis Accelerate from Laura Periman, MD - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Reflections on Lumenis Accelerate from Laura Periman, MD

Optometric Management caught up with Laura Periman, MD, at the Lumenis Accelerate Owner’s Summit in Chicago on August 28 to discuss what attendees could take away from the event, both in clinical pearls and workflows and in practice management lessons.

  • September 1, 2026

  • 4 min

Share

Clinical Report: Reflections on Lumenis Accelerate from Laura Periman, MD

Overview

Dr. Laura Periman discusses key takeaways from the Lumenis Accelerate Owner’s Summit, focusing on advancements in dry eye disease management through OptiLight and OptiLift technologies.

Background

The management of dry eye disease is a significant concern in ophthalmology, particularly as it affects a large patient population. Recent advancements in technologies such as intense pulsed light (IPL) and dynamic muscle stimulation (DMSt) offer new avenues for addressing underlying anatomical and functional issues associated with dry eye.

Data Highlights

No numerical data provided in the source material.

Key Findings

  • Attendees at the summit were primarily interested in expert management of dry eye disease.
  • OptiLift technology utilizes radiofrequency and DMSt to address lid laxity and improve eyelid function.
  • OptiLight and OptiLift technologies can be used sequentially to enhance treatment efficacy.
  • Effective management of dry eye includes addressing inflammation, meibomian gland dysfunction, and lid muscle weakness.

Clinical Implications

The integration of OptiLift technology into practice allows clinicians to address complex dry eye conditions.

Conclusion

The Lumenis Accelerate Owner’s Summit provided insights into the application of advanced technologies for managing dry eye disease.

Related Resources & Content

  1. Optometric Management, Reflections on Lumenis Accelerate from Cory Lappin, OD, 2026 -- Reflections on Lumenis Accelerate from Cory Lappin, OD
  2. Optometric Management, Reflections on Lumenis Accelerate from Stacy Winter, 2026 -- Reflections on Lumenis Accelerate from Stacy Winter
  3. Optometric Management, Lumenis Accelerate, 2026 -- Lumenis Accelerate
  4. American Academy of Ophthalmology, Dry Eye Syndrome Preferred Practice Pattern®, 2023 -- Dry Eye Syndrome Preferred Practice Pattern®
  5. FDA, Correspondence Generator, 2021 -- FDA Classification of IPL for Dry Eye
  6. Frontiers, Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction, 2026 -- Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction
  7. optometric management — Lumenis Summit Offers Strategies for Building and Marketing Specialty Services
  8. Dry Eye Syndrome Preferred Practice Pattern® - Ophthalmology
  9. Correspondence Generator (CorGen)
  10. Frontiers | Therapeutic Role of Intense Pulsed Light in Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
  11. Effectiveness and safety of intense pulsed light therapy for dry eye symptoms due to meibomian gland dysfunction-A systematic review and meta-analysis - PubMed
  12. Safety and efficacy of a novel intense pulsed light system in patients with meibomian gland dysfunction: a randomized, double-masked, intra-individual controlled study | International Ophthalmology | Springer Nature Link
  13. Technological Interventions for Dry Eye Disease: A Systematic Review and Random-Effects Network Meta-analysis of 3-Month Outcomes | Ophthalmology and Therapy | Springer Nature Link
  14. Intense Pulsed Light (IPL) for Meibomian Gland Dysfunction | Clinical Review Criteria

Original Source(s)

Reflections on Lumenis Accelerate from Laura Periman, MD

  • September 1, 2026

Related Content

Dry Eye Dx and Tx: <br>Tailoring the Tear Reservoir</br>

Women and Dry Eye

Presenters at Optometry's Meeting noted that hormonal status and cosmetic use can significantly affect test results and dry eye disease presentation.

AI Enhances Meibomian Gland Detection

AI-powered spectral imaging shown by proof-of-concept study to advance MGD diagnosis

  • June 16, 2026

  • 3 min